Update on recent advances in amyotrophic lateral sclerosis
Nilo Riva, Teuta Domi, Laura Pozzi, Christian Lunetta, Paride Schito, Edoardo Gioele Spinelli, Sara Cabras, Enrico Matteoni, Monica Consonni, Eleonora Dalla Bella, Federica Agosta, Massimo Filippi, Andrea Calvo, Angelo Quattrini
Abstract
In the last few years, our understanding of disease molecular mechanisms underpinning ALS has advanced greatly, allowing the first steps in translating into clinical practice novel research findings, including gene therapy approaches. Similarly, the recent advent of assistive technologies has greatly improved the possibility of a more personalized approach to supportive and symptomatic care, in the context of an increasingly complex multidisciplinary line of actions, which remains the cornerstone of ALS management. Against this rapidly growing background, here we provide an comprehensive update on the most recent studies that have contributed towards our understanding of ALS pathogenesis, the latest results from clinical trials as well as the future directions for improving the clinical management of ALS patients.